Response to Comments: MolDX: Phenotypic Biomarker Detection from Circulating Tumor Cells

This document is an administrative response to comments on LCD L38678 (MolDX: Phenotypic Biomarker Detection from Circulating Tumor Cells), noting the comment period (05/28/20–07/11/20), notice period start (06/10/21) and effective date (07/25/21). It records a title revision and summarizes received comments but does not specify any clinical coverage indications, limitations, documentation requirements, or frequency limits.